Douglas Berger Psychiatrist Tokyo, writes a Letter to the Editor in Psychiatric Times (date unknown) In their article “Are Placebo Controls Ethical in Antidepressant Clinical Trials?” (Psychiatric Times April 2000) Khan and Khan state that the FDA’s double-blind placebo controlled trial requirement for new antidepressant approval is not necessary in […]